<code id='AAAD99A822'></code><style id='AAAD99A822'></style>
    • <acronym id='AAAD99A822'></acronym>
      <center id='AAAD99A822'><center id='AAAD99A822'><tfoot id='AAAD99A822'></tfoot></center><abbr id='AAAD99A822'><dir id='AAAD99A822'><tfoot id='AAAD99A822'></tfoot><noframes id='AAAD99A822'>

    • <optgroup id='AAAD99A822'><strike id='AAAD99A822'><sup id='AAAD99A822'></sup></strike><code id='AAAD99A822'></code></optgroup>
        1. <b id='AAAD99A822'><label id='AAAD99A822'><select id='AAAD99A822'><dt id='AAAD99A822'><span id='AAAD99A822'></span></dt></select></label></b><u id='AAAD99A822'></u>
          <i id='AAAD99A822'><strike id='AAAD99A822'><tt id='AAAD99A822'><pre id='AAAD99A822'></pre></tt></strike></i>

          focus

          focus

          author:explore    Page View:3359
          Empty biotech lab with no people and green benches and cabinets. -- biotech coverage from STAT
          Adobe

          Demand for new lab space has plummeted by more than half since the end of 2021, and life science vacancy rates are the highest they’ve been in a decade amid the biotech industry’s ongoing downturn, according to a report released Tuesday by Jones Lang LaSalle, a commercial real estate services company

          Tenant demand, measured by the total amount of new space that companies are looking to lease, dropped from 25.3 million square feet at the end of 2021 to 10.1 million square feet by the second quarter of this year across eight top life science markets: Boston, the Bay Area, San Diego, Raleigh-Durham, Philadelphia, Seattle, Los Angeles, and the Washington, D.C., area.

          advertisement

          The real estate numbers presented in JLL’s annual life sciences report are yet another sign that the biotech industry, which outperformed the broader market for years, is in the midst of a slowdown. Lab space is increasingly going unused amid a supply glut, and more companies are looking to sublease space. Real estate observers say there are some signs these trends could turn around in the next year or two, though that is far from certain.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          As demand for Covid shots wanes, Moderna seeks its next success
          As demand for Covid shots wanes, Moderna seeks its next success

          RubyWallauforSTATModernachairmanNoubarAfeyanexudedstarpowerearlierthismonthashecommandedthespotlight

          read more
          STAT Summit: The economic case for universal basic health care
          STAT Summit: The economic case for universal basic health care

          MITeconomistAmyFinkelsteinchatswithSTAT'sBobHermanatthe2023STATSummit.STATFixingtheU.S.healthcaresys

          read more
          Guidelines to prevent youth baseball injuries need more muscle
          Guidelines to prevent youth baseball injuries need more muscle

          Apitcheratthe2018LittleLeagueWorldSeries.RobCarr/GettyImages“Weallknowthatweareinthemiddleofanepidem

          read more

          Roche drug slashes death risk in early

          Roche'sboothatthe2023ESMOconference.AndrewJoseph/STATMADRID—ARochedrugloweredtheriskofrecurrenceorde